PFBT
AXSM icon

Parkside Financial Bank & Trust’s Axsome Therapeutics AXSM Stock Holding History

Parkside Financial Bank & Trust’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.47K Buy
56
+33
+143% +$5.7K ﹤0.01% 1602
2025
Q4 		$4.2K Hold
23
– – ﹤0.01% 1862
2025
Q3 		$2.79K Hold
23
– – ﹤0.01% 1903
2025
Q2 		$2.4K Buy
23
+8
+53% +$847 ﹤0.01% 1935
2025
Q1 		$1.75K Buy
+15
New +$1.71K ﹤0.01% 1922

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parkside Financial Bank & Trust's AXSM Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its Axsome Therapeutics (AXSM) stake by 143% in Q1 2026, buying an estimated $5.7K and bringing the position to 56 shares worth $9.47K. The position accounts for ﹤0.01% of the portfolio, ranked #1602.

Parkside Financial Bank & Trust first reported a position in AXSM in Q1 2025 and has held it in 5 quarters since. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Parkside Financial Bank & Trust held 56 shares of Axsome Therapeutics worth $9.47K as of Q1 2026.
  • Parkside Financial Bank & Trust bought 33 Axsome Therapeutics shares in Q1 2026, an estimated $5.7K.
  • Axsome Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1602 holding.
  • Parkside Financial Bank & Trust first reported a position in Axsome Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.